Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons
  • Published Date:

    Aug 2002

  • Source:
    Emerg Infect Dis. 8(8):833-841.
Filetype[PDF-288.17 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 807.22 KB]
    Personal Author:
    Kaufmann, A. F.; Meltzer, M. I.; Schmid, G. P.;
    Published Date:
    1997 Apr-Jun
    Source:
    Emerg Infect Dis. 3(2):83-94.
    Description:
    Understanding and quantifying the impact of a bioterrorist attack are essential in developing public health preparedness for such an attack. We constructed a model that compares the impact of three classic agents of biologic warfare (Bacillus anthrac...
    File Type:
    Filetype[PDF - 807.22 KB]
  2. Filetype[PDF - 468.34 KB]
    Corporate Authors:
    National Center for Infectious Diseases (U.S.). Centers for Disease Control and Prevention (U.S.).
    Conference Authors:
    Bacillus anthracis Bioterrorism Research Priorities for Public Health Response (2001 : Atlanta, GA)
    Published Date:
    7/24/02
    Description:
    This meeting provided a forum for 132 representatives from the Department of Health and Human Services (Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Institutes of Health (NIH)), Environmental Prot...
    File Type:
    Filetype[PDF - 468.34 KB]
  3. Filetype[PDF - 563.76 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    10/22/01
    Series:
    HAN ; 041
    Description:
    Monday, October 22, 2001, 20:54 EDT (8:54 PM EDT)CDCHAN-00041-2001-10-22-ADV-NThe antimicrobial susceptibility patterns of eleven Bacillus anthracis isolates associated with intentional exposures on the east coast have been determined. The susceptibi...
    File Type:
    Filetype[PDF - 563.76 KB]
  4. Filetype[PDF - 66.12 KB]
    Personal Author:
    Zoon, K. C.
    Published Date:
    1999 Jul-Aug
    Source:
    Emerg Infect Dis. 5(4):534-536.
    File Type:
    Filetype[PDF - 66.12 KB]
  5. Filetype[PDF - 349.07 KB]
    Personal Author:
    Dennis, David T.; Inglesby, Thomas V.; Henderson, Donald A.; Bartlett, John G.; Ascher, Michael S.; Eitzen, Edward; Fine, Anne D.; Friedlander, Arthur M.; Hauer, Jerome; Layton, Marcelle M.; Lillibridge, Scott R.; McDade, Joseph E.; Osterholm, Michael T.; O’Toole, Tara; Parker, Gerald; Perl, Trish M.; Russell, Philip K.; Tonat, Kevin;
    Corporate Authors:
    Working Group on Civilian Biodefense.
    Published Date:
    June 6, 2001
    Source:
    JAMA : the journal of the American Medical Association. 2001; 285(21):2763-73.
    Description:
    OBJECTIVE: The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a biological weapon against a civilian population.PARTICIPAN...
    Status:
    current
    File Type:
    Filetype[PDF - 349.07 KB]